Dubravka Smiljkovic

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils.

Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils.

Journal: Cells

Published: December 07, 2023

Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph+ Chronic Myeloid Leukemia.

Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph+ Chronic Myeloid Leukemia.

Journal: Cells

Published: August 29, 2022

Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.

Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.

Journal: American journal of cancer research

Published: June 29, 2022

Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?

Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?

Journal: The Journal of allergy and clinical immunology

Published: February 17, 2022

Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils.

Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils.

Journal: The Journal of allergy and clinical immunology

Published: February 15, 2022

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

Journal: Cancers

Published: December 31, 2021

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.

Journal: Neoplasia (New York, N.Y.)

Published: June 25, 2021

Cell-based and antibody-mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.

Cell-based and antibody-mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.

Journal: Stem cells translational medicine

Published: April 08, 2020

Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells.

Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells.

Journal: Pharmacological research

Published: November 12, 2019

Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis.

Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis.

Journal: The journal of allergy and clinical immunology. In practice

Published: September 03, 2019

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.

Journal: Veterinary and comparative oncology

Published: April 01, 2019

Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity.

Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity.

Journal: Scientific reports

Published: April 30, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026